SLG
62
-4
NOC
40
-10
DRI
56
2
FTI
78
-3
KEY
46
-2
JCI
61
-2
TAP
64
4
CTSH
65
-3
TEL
74
3
GOOG
69
-10
IP
70
-3
PDCO
30
-6
C
62
-3
LB
63
-4
GOOGL
59
-8
FLS
76
-2
FRT
48
2
SWKS
33
-10
ADM
24
2
EMC
53
-3
SLG
62
-4
NOC
40
-10
DRI
56
2
FTI
78
-3
KEY
46
-2
JCI
61
-2
TAP
64
4
CTSH
65
-3
TEL
74
3
GOOG
69
-10
IP
70
-3
PDCO
30
-6
C
62
-3
LB
63
-4
GOOGL
59
-8
FLS
76
-2
FRT
48
2
SWKS
33
-10
ADM
24
2
EMC
53
-3
Financhill
Back

Black Diamond Therapeutics Quote, Financials, Valuation and Earnings

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
34

BDTX
Black Diamond Therapeutics

Last Price:
2.87
Seasonality Move:
21.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Black Diamond Therapeutics Price Quote

$2.87
-0.26 (-8.31%)
(Updated: November 14, 2024 at 5:55 PM ET)

Black Diamond Therapeutics Key Stats

Sell
34
Black Diamond Therapeutics (BDTX) is a Sell
Day range:
$3.10 - $3.32
52-week range:
$1.95 - $7.66
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.88%
Volume:
332.6K
Avg. volume:
699.1K
1-year change:
64.74%
Market cap:
$183.3M
Revenue:
$0
EPS:
$-1.33

How Much Does Black Diamond Therapeutics Make?

Data Unavailable

Is Black Diamond Therapeutics Growing As A Company?

Data Unavailable

Black Diamond Therapeutics Stock Price Performance

What Is Black Diamond Therapeutics 52-Week High & Low?

Black Diamond Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Black Diamond Therapeutics?

Is Black Diamond Therapeutics Cash Flow Positive?

  • What Is BDTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$61.2M
  • What Is Black Diamond Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $25.2M
  • What Is Black Diamond Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.4M

Black Diamond Therapeutics Return On Invested Capital

Data Unavailable

Black Diamond Therapeutics Earnings Date & Stock Price

Black Diamond Therapeutics Competitors

Black Diamond Therapeutics Dividend Yield

Black Diamond Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 21.5%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.50
Upside from Last Price: 363.26%

Major Shareholders

  • How many BDTX shares are owned by institutional investors?
    95.7M BDTX shares are owned by institutional investors
  • How many BDTX shares are owned by insiders?
    1.2M BDTX shares are owned by insiders